Teva Pharmaceutical Industries Limited
TEVA
$26.88
$0.160.60%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 174.24% | 65.12% | -168.48% | -192.68% | 58.96% |
| Total Depreciation and Amortization | -4.07% | -5.28% | -8.03% | -8.15% | -11.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.61% | 51.48% | 123.27% | 167.06% | -28.49% |
| Change in Net Operating Assets | -1,905.88% | -118.10% | -190.00% | -504.17% | 737.50% |
| Cash from Operations | -42.56% | 19.01% | -8.86% | -8.85% | 60.41% |
| Capital Expenditure | 0.00% | -2.25% | 1.96% | 5.32% | 11.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | 100.00% | -- | -- |
| Divestitures | -2.56% | 518.18% | -9.09% | -36.76% | -57.14% |
| Other Investing Activities | -9.67% | 3.00% | -7.26% | -11.50% | 4.80% |
| Cash from Investing | -13.13% | 12.39% | -8.81% | -18.18% | 6.71% |
| Total Debt Issued | -- | 229.29% | -- | -- | -100.00% |
| Total Debt Repaid | -229.95% | -63.89% | -77.00% | 66.18% | 71.23% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -54.43% | -16.29% | -4.75% | 29.25% | -70.50% |
| Cash from Financing | -69.23% | -6.30% | -149.19% | 6.38% | 17.33% |
| Foreign Exchange rate Adjustments | -700.00% | 116.10% | 82.88% | -480.00% | -68.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 100.00% | -- | -- |
| Net Change in Cash | -204.40% | 76.46% | -258.77% | -81.42% | 13,462.50% |